News & Press Release
2023
- All Categories
- For the Press
- Announcements
- HR and Organization
- Product Information
-
- 2023-12-08 Product Information Daito Launched Authorized Generic of Wilson’s Disease Treatment “NOBELZIN®” (copper absorption inhibitor)
- 2023-12-06 Product Information Daito’s Authorized Generic of Wilson’s Disease Treatment “NOBELZIN®” (copper absorption inhibitor) Receives Additional Indication Approval
- 2023-11-16 Announcements Nobelpharma Received Chairperson’s Award 2023 “Sukoyaka Family 21” (National Campaign for Maternal and Child Health)
- 2023-10-30 Product Information HYFTOR (sirolimus 2 mg/g gel) Launched in Europe
- 2023-09-21 Announcements Investigator-Initiated Phase II Trial Completed: Sirolimus Gel for Vascular Abnormality-associated Skin Lesions
- 2023-09-01 Announcements HYFTOR (sirolimus 2 mg/g gel) Approved by The Medicines and Healthcare products Regulatory Agency (MHRA)
- 2023-05-29 Announcements “HYFTOR” Receives Marketing Authorization in EU for Facial Angiofibroma associated with Tuberous Sclerosis Complex
- 2023-04-18 Product Information Sirolimus Gel Approved by China’s National Medical Products Administration
- 2023-04-12 Product Information Zinc Kit (In-Vitro Diagnostic Reagent) “ACCUREAD Zn” General-Purpose Spectrophotometric Analyzer “ACCUREAD” Launched
- 2023-02-01 Product Information 『 NOBELZIN® G ranule s 5% 』 L aunched for Treatment of Wilson’s D isease (copper absorption inhibitor) and Hypozincemia